Both of these receptors were found in blood serum and up-regulated along with ADAM17, known to affect L-selectin (CD62) shedding, with ADAM17, a TNF-α convertase, also upregulated in inflammatory bowel disease (IBD) [213,214]. Here, SELL is linked to inflammatory bowel disease.